Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definition
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Unpaid sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 U.S. telemedicine industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
Chapter 3 US Telemedicine Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic diseases
3.3.1.2 Growing number of smartphone users
3.3.1.3 Technological advancements related to mobile phones and internet
3.3.1.4 Long waiting time in hospitals for disease treatment
3.3.1.5 Favorable government initiatives
3.3.2 Industry pitfalls & challenges
3.3.2.1 Security and privacy concerns
3.3.2.2 Stringent regulatory policies and limited reimbursement in the U.S.
3.4 Growth potential analysis
3.4.1 By service
3.4.2 By type
3.4.3 By specialty
3.4.4 By component
3.4.5 By delivery mode
3.5 COVID-19 impact analysis
3.6 Penetration/adoption in U.S. hospitals
3.7 Reimbursement scenario in U.S.
3.8 Telemedicine modalities
3.9 Government initiatives
3.9.1 U.S. Department of Agriculture (USDA) Initiative
3.9.2 Rural Health Care (RHC) Program
3.9.3 U.S. Department of Defense Initiative
3.10 Telemedicine future trends
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive analysis of major players
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 US Telemedicine Market, By Service
5.1 Key segment trends
5.2 Tele-consulting
5.2.1 Market size, 2018 – 2032 (USD Million)
5.3 Tele-monitoring
5.3.1 Market size, 2018 – 2032 (USD Million)
5.4 Tele-education/training
5.4.1 Market size, 2018 – 2032 (USD Million)
5.5 Others
5.5.1 Market size, 2018 – 2032 (USD Million)
Chapter 6 US Telemedicine Market, By Type
6.1 Key segment trends
6.2 Telehospital
6.2.1 Market size, 2018 – 2032 (USD Million)
6.2.2 Integrated delivery network (IDN)
6.2.2.1 Market size, 2018 – 2032 (USD Million)
6.2.3 Academic medical center (AMC)
6.2.3.1 Market size, 2018 – 2032 (USD Million)
6.2.4 Large independent hospitals
6.2.4.1 Market size, 2018 – 2032 (USD Million)
6.2.5 Medium independent hospitals
6.2.5.1 Market size, 2018 – 2032 (USD Million)
6.2.6 Small hospitals
6.2.6.1 Market size, 2018 – 2032 (USD Million)
6.2.7 Others
6.2.7.1 Market size, 2018 – 2032 (USD Million)
6.3 Telehome
6.3.1 Market size, 2018 – 2032 (USD Million)
Chapter 7 US Telemedicine Market, By Specialty
7.1 Key segment trends
7.2 Cardiology
7.2.1 Market size, 2018 – 2032 (USD Million)
7.3 Gynecology
7.3.1 Market size, 2018 – 2032 (USD Million)
7.4 Neurology
7.4.1 Market size, 2018 – 2032 (USD Million)
7.5 Orthopedics
7.5.1 Market size, 2018 – 2032 (USD Million)
7.6 Dermatology
7.6.1 Market size, 2018 – 2032 (USD Million)
7.7 Metal health
7.7.1 Market size, 2018 – 2032 (USD Million)
7.8 Critical care
7.8.1 Market size, 2018 – 2032 (USD Million)
7.9 Neonatology
7.9.1 Market size, 2018 – 2032 (USD Million)
7.10 Others
7.10.1 Market size, 2018 – 2032 (USD Million)
Chapter 8 US Telemedicine Market, By Component
8.1 Key segment trends
8.2 Hardware
8.2.1 Market size, 2018 – 2032 (USD Million)
8.3 Software
8.3.1 Market size, 2018 – 2032 (USD Million)
8.4 Services
8.4.1 Market size, 2018 – 2032 (USD Million)
Chapter 9 US Telemedicine Market, By Delivery Mode
9.1 Key segment trends
9.2 Web/Mobile
9.2.1 Market size, 2018 – 2032 (USD Million)
9.2.2 Telephonic
9.2.2.1 Market size, 2018 – 2032 (USD Million)
9.2.3 Visualized
9.2.3.1 Market size, 2018 – 2032 (USD Million)
9.3 Call Centers
9.3.1 Market size, 2018 – 2032 (USD Million)
Chapter 10 Company Profiles
10.1 Allscripts Healthcare Solutions Inc
10.1.1 Business overview
10.1.2 Financial data
10.1.3 Product landscape
10.1.4 Strategic outlook
10.1.5 SWOT analysis
10.2 AMD Global Telemedicine, Inc.
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Product landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 American Well
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Product landscape
10.3.4 Strategic outlook
10.3.5 SWOT analysis
10.4 Oracle Corporation (Cerner)
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Product landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 Cisco
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Product landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Eagle Telemedicine
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Product landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 Honeywell International Inc.
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Product landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 Koninklijke Philips N.V.
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Product landscape
10.8.4 Strategic outlook
10.8.5 SWOT analysis
10.9 McKesson Corporation
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Product landscape
10.9.4 Strategic outlook
10.9.5 SWOT analysis
10.10 OBS Medical
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Product landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 SOC Telemed
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Product landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Specialist Telemed
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Product landscape
10.12.4 Strategic outlook
10.12.5 SWOT analysis
10.13 Teladoc Health
10.13.1 Business overview
10.13.2 Financial data
10.13.3 Product landscape
10.13.4 Strategic outlook
10.13.5 SWOT analysis
